Prognostic factors and staging systems for multiple myeloma: comparisons between the Medical Research Council studies in the United Kingdom and the Southwest Oncology Group studies in the United States.
Kelly
K A
KA
University of Birmingham, West Midlands Cancer Research Campaign Clinical Trials Unit, Queen Elizabeth Hospital, U.K.
Durie
B
B
Maclennan
I C
IC
D000368:Aged; D002118:Calcium / Q000097:blood; D005260:Female; D006454:Hemoglobins / Q000032:analysis; D006801:Humans; D008297:Male; D008875:Middle Aged; D009101:Multiple Myeloma / Q000097:blood / Q000473:pathology*; D009367:Neoplasm Staging; D011379:Prognosis; D006113:United Kingdom; D014481:United States; D001613:beta 2-Microglobulin / Q000032:analysis
D006454:Hemoglobins; D001613:beta 2-Microglobulin; D002118:Calcium